Medical News

RSS

Crosstex International introduces customized surgical masks

Cantel Medical Corp., announced today the launch of a new, unique design of medical face masks - the SecureFit™ series by Crosstex International, a Cantel subsidiary and a leading U.S. manufacturer of medical face masks. The SecureFit™ series of masks addresses scientific research that points to poorly fitting masks as a major hindrance to their effectiveness.

15 Oct 2010

Medtronic CoreValve System IDE for transcatheter aortic valve implantation receives FDA approval

Medtronic, Inc. today announced U.S. Food and Drug Administration (FDA) conditional approval for its Investigational Device Exemption (IDE) application and pivotal clinical trial protocol to begin evaluating the Medtronic CoreValve System for transcatheter aortic valve implantation (TAVI).

15 Oct 2010

Enrollment complete in Inhibitex's FV-100 Phase II clinical trial in shingles patients

Inhibitex, Inc., announced today that it has completed enrollment in a Phase II clinical trial of FV-100 in shingles (herpes zoster) patients. The objectives of the trial are to further evaluate the safety of FV-100 and its potential therapeutic benefit in reducing the severity and duration of shingles-associated pain, the incidence of post herpetic neuralgia (PHN), and the time to heal shingles-related lesions.

15 Oct 2010

Essilor International to acquire 50% of Shamir Optical

Shamir Optical Industry Ltd. Kibbutz Shamir and Essilor International today announced that they have signed an agreement whereby Essilor will, through a series of transactions, acquire 50% of Shamir Optical. As a result of these transactions, Kibbutz Shamir and Essilor will each own 50% of Shamir Optical.

15 Oct 2010

Watson Laboratories receives FDA approval for Amlodipine capsules

Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration on its Abbreviated New Drug Application (ANDA) for Amlodipine Besylate/Benazepril 5/20mg, 10/20mg, 2.5/10mg, and 5/10mg capsules, the generic equivalent to Novartis' Lotrel capsules.

15 Oct 2010

Pericytes regulate blood-brain barrier

While the blood-brain barrier (BBB) protects the brain from harmful chemicals occurring naturally in the blood, it also obstructs the transport of drugs to the brain. In an article in Nature scientists at the Swedish medical university Karolinska Institutet now present a potential solution to the problem. The key to the BBB is a cell-type in the blood vessel walls called pericytes, and the researchers hope that their findings will one day contribute to new therapies for diseases like Alzheimer's and stroke.

15 Oct 2010

NovaBay to present two poster presentations at IDSA Annual Meeting

NovaBay Pharmaceuticals, Inc. a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, announces that it will deliver two poster presentations on its compounds at the 48th Annual Meeting of the Infectious Diseases Society of America (IDSA).

15 Oct 2010

Allegheny expects $0.26 net income for third quarter 2010

Allegheny Technologies Incorporated today provided guidance for the third quarter 2010. ATI expects net income per share for the third quarter 2010 before certain charges to be approximately $0.26.

15 Oct 2010

Bristol-Myers, Otsuka launch My SPRYCEL Support program to assist patients with CML

Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced the launch of My SPRYCEL (dasatinib) Support, a useful resource to assist adult patients with chronic myeloid leukemia (CML) who are taking SPRYCEL.

15 Oct 2010

New comprehensive program for medical electronic device designers

Canon Communications today announced the formation of a comprehensive program to assist designers, developers, and engineering managers involved in the design of electronics-based medical devices. The DesignMED conference and exposition is a collaborative project between the company's Medical Device Group-Medical Electronics Design (MED), EDN, and MD+DI-and its Event Division.

15 Oct 2010

CVS Caremark to present client experiences on innovative approaches at AMCP Conference

CVS Caremark is presenting data at the Academy of Managed Care Pharmacy (AMCP) 2010 Educational Conference illustrating how innovative approaches to traditional plan designs can help clients reduce drug spend, improve generic dispensing rates (GDR) and minimize member disruption.

15 Oct 2010

AstraZeneca launches new campaign on depression through Facebook and Twitter

AstraZeneca is launching a new campaign called "Take on Depression" through a "Take on Depression" Facebook page and a @FaceDepression Twitter feed to support, educate, and inspire those affected by bipolar depression and major depressive disorder (MDD), also known as depression.

15 Oct 2010

NASA software could help interpret medical imagery

NASA software used to enhance Earth science imagery could help interpret medical imagery. The new MED-SEG system, developed by Bartron Medical Imaging Inc. of Largo, Md., relies on an innovative software program developed at NASA to help doctors analyze mammograms, ultrasounds, digital X-rays and other medical imaging tests.

15 Oct 2010

NIH awards $1.2M for study on discharge decisions at hospitals

A Georgia State University professor and an Emory University surgeon have received a $1.2 million grant from the National Institutes of Health for a joint research project to study discharge decisions at hospitals.

15 Oct 2010

Acorda presents new analysis of AMPYRA tablets at ECTRIMS Congress

Acorda Therapeutics, Inc. today announced that a new analysis of AMPYRA (dalfampridine) Extended Release Tablets, 10 mg data examining walking improvement in treatment responders has been presented at the 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).

15 Oct 2010

NYSE Amex grants PharmAthene extension to demonstrate listing compliance

PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that based on information provided by PharmAthene in its compliance plan, and discussions with Exchange staff, the NYSE Amex LLC has determined that the Company made a reasonable demonstration of its ability to regain compliance with the NYSE Amex listing requirements and granted PharmAthene an extension until January 26, 2012 to demonstrate its compliance.

15 Oct 2010

Medicare actuary says changes in advantage plans will mean more cost for some seniors

Politico obtained an analysis by Richard Foster, the actuary for the Centers for Medicare and Medicaid, which that the health law will mean increased costs for seniors in Medicare Advantage plans.

15 Oct 2010

$Spinal fractures remain undiagnosed and untreated$

Spinal fractures remain undiagnosed and untreated

A new report issued by the International Osteoporosis Foundation (IOF) for World Osteoporosis Day puts the spotlight on the severe impact of spinal fractures and calls on health professionals to recognize the signs of these fractures in their patients.

15 Oct 2010

UCSD certification for SynCardia temporary Total Artificial Heart to commence: SynCardia Systems

SynCardia Systems, Inc. announced today that the University of California, San Diego (UCSD), led by Stuart W. Jamieson, M.B., F.R.C.S. (photo), Head of Cardiothoracic Surgery, will begin certification to implant the SynCardia temporary Total Artificial Heart. Efforts to bring the Total Artificial Heart to UCSD were led by world renowned heart surgeon Dr. Jack Copeland, who joined the faculty in July.

15 Oct 2010

World Food Prize recipients call for investment in agriculture in developing countries

The 2010 World Food Prize recipients say despite the economic situation "it's no time for the United States to back off a historic pledge to invest in boosting the production of the world's poorest farmers," the Des Moines Register reports.

15 Oct 2010

Medical News

Crosstex International introduces customized surgical masks

Medtronic CoreValve System IDE for transcatheter aortic valve implantation receives FDA approval

Enrollment complete in Inhibitex's FV-100 Phase II clinical trial in shingles patients

Essilor International to acquire 50% of Shamir Optical

Watson Laboratories receives FDA approval for Amlodipine capsules

Pericytes regulate blood-brain barrier

NovaBay to present two poster presentations at IDSA Annual Meeting

Allegheny expects $0.26 net income for third quarter 2010

Bristol-Myers, Otsuka launch My SPRYCEL Support program to assist patients with CML

New comprehensive program for medical electronic device designers

CVS Caremark to present client experiences on innovative approaches at AMCP Conference

AstraZeneca launches new campaign on depression through Facebook and Twitter

NASA software could help interpret medical imagery

NIH awards $1.2M for study on discharge decisions at hospitals

Acorda presents new analysis of AMPYRA tablets at ECTRIMS Congress

NYSE Amex grants PharmAthene extension to demonstrate listing compliance

Medicare actuary says changes in advantage plans will mean more cost for some seniors

Spinal fractures remain undiagnosed and untreated

UCSD certification for SynCardia temporary Total Artificial Heart to commence: SynCardia Systems

World Food Prize recipients call for investment in agriculture in developing countries

Voltammetry and machine learning for real-time neurotransmitter detection

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

Latest News